EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

Lisan H Kuijper iD, Laura Y L Kummer, Laura Fernandez Blanco, Karlijn van der Straten, Mathieu A F Claireaux, Amélie V Bos, Miranda C Dieker-Meijer, Tineke Jorritsma, Mariël C Duurland, Maurice Steenhuis, Juan J Garcia Vallejo, Koos P J van Dam und 12 weitere

European Journal of Immunology · 2026

DOI: 10.1002/eji.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2026. Verfasst von Lisan H Kuijper und 23 weiteren Autor:innen. Beteiligte Einrichtung: Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: SARS-CoV-2, Memory B Cells, COVID-19, B-Lymphocytes. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Sanquin Blood Supply program grant PPOC OPTIMAL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After antigen encounter, long‐lived antibody‐secreting cells (ASC) secrete high‐affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re‐exposure and predominantly generate shorter‐lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as “bystander activation”. This antigen‐independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS‐CoV‐2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen‐specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen‐specific B cell responses was simultaneously performed using multiparameter high‐dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS‐CoV‐2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short‐term increase in influenza‐specific IgG+ DN3 B cells, RSV‐specific IgG+ CD11c+ activated B cells, and TT‐specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS‐CoV‐2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Memory B CellsCOVID-19B-LymphocytesImmunity, HumoralCOVID-19 VaccinesHumansAntibodies, ViralAdultLymphocyte ActivationVaccinationBystander EffectTetanus ToxoidFemaleImmunologic MemoryCell Differentiation

Stichwörter der Autor:innen

DN3IgG+ activated B cellsantibodiesantibody‐secreting cellsmemory B cellsnoncognate antigenserological memory

Substanzen

Antibodies, ViralCOVID-19 VaccinesTetanus Toxoid

Autor:innen und Institutionen

  • Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.
  • Department of Neurology and Neurophysiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Amsterdam, the Netherlands.
  • Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Department of Clinical Neurophysiology, St. Antonius Hospital, Nieuwegein, the Netherlands.

ORCID-Profile: Lisan H Kuijper, Theo Rispens

Förderung

  • ZonMw
  • Sanquin Blood Supply program grant PPOC OPTIMAL

Zitieren

APA

Kuijper, L. H., Kummer, L. Y. L., Blanco, L. F., van der Straten, K., Claireaux, M. A. F., Bos, A. V., Dieker-Meijer, M. C., Jorritsma, T., Duurland, M. C., Steenhuis, M., Vallejo, J. J. G., van Dam, K. P. J., Stalman, E. W., Wieske, L., Tas, S. W., Boekel, L., Wolbink, G. J., Rispens, T., Kuijpers, T. W., …, & T2B! immunity against SARS‐CoV‐2 study group (2026). SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults. European Journal of Immunology. https://doi.org/10.1002/eji.70127

Vancouver

Kuijper LH, Kummer LYL, Blanco LF, van der Straten K, Claireaux MAF, Bos AV, et al. SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults. European Journal of Immunology. 2026. doi:10.1002/eji.70127

BibTeX
@article{Kuijper2026,
  author = {Kuijper, Lisan H and Kummer, Laura Y L and Blanco, Laura Fernandez and van der Straten, Karlijn and Claireaux, Mathieu A F and Bos, Amélie V and Dieker-Meijer, Miranda C and Jorritsma, Tineke and Duurland, Mariël C and Steenhuis, Maurice and Vallejo, Juan J Garcia and van Dam, Koos P J and Stalman, Eileen W and Wieske, Luuk and Tas, Sander W and Boekel, Laura and Wolbink, Gert-Jan and Rispens, Theo and Kuijpers, Taco W and Eftimov, Filip and van Gils, Marit J and Ten Brinke, Anja and van Ham, S Marieke and T2B! immunity against SARS‐CoV‐2 study group, T2B! immunity against SARS‐CoV‐2 study group},
  title = {SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults},
  journal = {European Journal of Immunology},
  year = {2026},
  doi = {10.1002/eji.70127}
}
Kostenlos starten →